Global Non-Invasive Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Non-Invasive Cancer Diagnostics market size was valued at US$ 106160 million in 2023. With growing demand in downstream market, the Non-Invasive Cancer Diagnostics is forecast to a readjusted size of US$ 140130 million by 2030 with a CAGR of 4.0% during review period.
The research report highlights the growth potential of the global Non-Invasive Cancer Diagnostics market. Non-Invasive Cancer Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-Invasive Cancer Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-Invasive Cancer Diagnostics market.
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.%li%
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Non-Invasive Cancer Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-Invasive Cancer Diagnostics market. It may include historical data, market segmentation by Type (e.g., CTCs, CTNAS), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-Invasive Cancer Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-Invasive Cancer Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-Invasive Cancer Diagnostics industry. This include advancements in Non-Invasive Cancer Diagnostics technology, Non-Invasive Cancer Diagnostics new entrants, Non-Invasive Cancer Diagnostics new investment, and other innovations that are shaping the future of Non-Invasive Cancer Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-Invasive Cancer Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Non-Invasive Cancer Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-Invasive Cancer Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-Invasive Cancer Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-Invasive Cancer Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-Invasive Cancer Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-Invasive Cancer Diagnostics market.
Market Segmentation:
Non-Invasive Cancer Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Non-Invasive Cancer Diagnostics market size was valued at US$ 106160 million in 2023. With growing demand in downstream market, the Non-Invasive Cancer Diagnostics is forecast to a readjusted size of US$ 140130 million by 2030 with a CAGR of 4.0% during review period.
The research report highlights the growth potential of the global Non-Invasive Cancer Diagnostics market. Non-Invasive Cancer Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-Invasive Cancer Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-Invasive Cancer Diagnostics market.
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.%li%
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Non-Invasive Cancer Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-Invasive Cancer Diagnostics market. It may include historical data, market segmentation by Type (e.g., CTCs, CTNAS), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-Invasive Cancer Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-Invasive Cancer Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-Invasive Cancer Diagnostics industry. This include advancements in Non-Invasive Cancer Diagnostics technology, Non-Invasive Cancer Diagnostics new entrants, Non-Invasive Cancer Diagnostics new investment, and other innovations that are shaping the future of Non-Invasive Cancer Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-Invasive Cancer Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Non-Invasive Cancer Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-Invasive Cancer Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-Invasive Cancer Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-Invasive Cancer Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-Invasive Cancer Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-Invasive Cancer Diagnostics market.
Market Segmentation:
Non-Invasive Cancer Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- CTCs
- CTNAS
- Exosomes
- Blood
- Urine
- Saliva
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gen-Probe Inc
- Digene Corporation
- Quest Diagnostics Inc
- Cancer, Genetics Inc
- BIOVIEW Inc
- AVIVA Biosciences Corporation
- Laboratory Corporation of America Holdings (LabCorp)
- A&G Pharmaceutical
- Affymetrix Inc
- Precision Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Invasive Cancer Diagnostics Market Size 2019-2030
2.1.2 Non-Invasive Cancer Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Non-Invasive Cancer Diagnostics Segment by Type
2.2.1 CTCs
2.2.2 CTNAS
2.2.3 Exosomes
2.3 Non-Invasive Cancer Diagnostics Market Size by Type
2.3.1 Non-Invasive Cancer Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Non-Invasive Cancer Diagnostics Segment by Application
2.4.1 Blood
2.4.2 Urine
2.4.3 Saliva
2.5 Non-Invasive Cancer Diagnostics Market Size by Application
2.5.1 Non-Invasive Cancer Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
3 NON-INVASIVE CANCER DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Non-Invasive Cancer Diagnostics Market Size Market Share by Players
3.1.1 Global Non-Invasive Cancer Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Non-Invasive Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE CANCER DIAGNOSTICS BY REGIONS
4.1 Non-Invasive Cancer Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Non-Invasive Cancer Diagnostics Market Size Growth (2019-2024)
4.3 APAC Non-Invasive Cancer Diagnostics Market Size Growth (2019-2024)
4.4 Europe Non-Invasive Cancer Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024)
5.2 Americas Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)
5.3 Americas Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Cancer Diagnostics Market Size by Region (2019-2024)
6.2 APAC Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)
6.3 APAC Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Invasive Cancer Diagnostics by Country (2019-2024)
7.2 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)
7.3 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Invasive Cancer Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE CANCER DIAGNOSTICS MARKET FORECAST
10.1 Global Non-Invasive Cancer Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Non-Invasive Cancer Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Non-Invasive Cancer Diagnostics Forecast
10.1.3 APAC Non-Invasive Cancer Diagnostics Forecast
10.1.4 Europe Non-Invasive Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Non-Invasive Cancer Diagnostics Forecast
10.2 Americas Non-Invasive Cancer Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Non-Invasive Cancer Diagnostics Market Forecast
10.2.2 Canada Non-Invasive Cancer Diagnostics Market Forecast
10.2.3 Mexico Non-Invasive Cancer Diagnostics Market Forecast
10.2.4 Brazil Non-Invasive Cancer Diagnostics Market Forecast
10.3 APAC Non-Invasive Cancer Diagnostics Forecast by Region (2025-2030)
10.3.1 China Non-Invasive Cancer Diagnostics Market Forecast
10.3.2 Japan Non-Invasive Cancer Diagnostics Market Forecast
10.3.3 Korea Non-Invasive Cancer Diagnostics Market Forecast
10.3.4 Southeast Asia Non-Invasive Cancer Diagnostics Market Forecast
10.3.5 India Non-Invasive Cancer Diagnostics Market Forecast
10.3.6 Australia Non-Invasive Cancer Diagnostics Market Forecast
10.4 Europe Non-Invasive Cancer Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Non-Invasive Cancer Diagnostics Market Forecast
10.4.2 France Non-Invasive Cancer Diagnostics Market Forecast
10.4.3 UK Non-Invasive Cancer Diagnostics Market Forecast
10.4.4 Italy Non-Invasive Cancer Diagnostics Market Forecast
10.4.5 Russia Non-Invasive Cancer Diagnostics Market Forecast
10.5 Middle East & Africa Non-Invasive Cancer Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Non-Invasive Cancer Diagnostics Market Forecast
10.5.2 South Africa Non-Invasive Cancer Diagnostics Market Forecast
10.5.3 Israel Non-Invasive Cancer Diagnostics Market Forecast
10.5.4 Turkey Non-Invasive Cancer Diagnostics Market Forecast
10.5.5 GCC Countries Non-Invasive Cancer Diagnostics Market Forecast
10.6 Global Non-Invasive Cancer Diagnostics Forecast by Type (2025-2030)
10.7 Global Non-Invasive Cancer Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Gen-Probe Inc
11.1.1 Gen-Probe Inc Company Information
11.1.2 Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Offered
11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Gen-Probe Inc Main Business Overview
11.1.5 Gen-Probe Inc Latest Developments
11.2 Digene Corporation
11.2.1 Digene Corporation Company Information
11.2.2 Digene Corporation Non-Invasive Cancer Diagnostics Product Offered
11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Digene Corporation Main Business Overview
11.2.5 Digene Corporation Latest Developments
11.3 Quest Diagnostics Inc
11.3.1 Quest Diagnostics Inc Company Information
11.3.2 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Offered
11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Quest Diagnostics Inc Main Business Overview
11.3.5 Quest Diagnostics Inc Latest Developments
11.4 Cancer, Genetics Inc
11.4.1 Cancer, Genetics Inc Company Information
11.4.2 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Offered
11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Cancer, Genetics Inc Main Business Overview
11.4.5 Cancer, Genetics Inc Latest Developments
11.5 BIOVIEW Inc
11.5.1 BIOVIEW Inc Company Information
11.5.2 BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Offered
11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BIOVIEW Inc Main Business Overview
11.5.5 BIOVIEW Inc Latest Developments
11.6 AVIVA Biosciences Corporation
11.6.1 AVIVA Biosciences Corporation Company Information
11.6.2 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Offered
11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AVIVA Biosciences Corporation Main Business Overview
11.6.5 AVIVA Biosciences Corporation Latest Developments
11.7 Laboratory Corporation of America Holdings (LabCorp)
11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Information
11.7.2 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Offered
11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Laboratory Corporation of America Holdings (LabCorp) Main Business Overview
11.7.5 Laboratory Corporation of America Holdings (LabCorp) Latest Developments
11.8 A&G Pharmaceutical
11.8.1 A&G Pharmaceutical Company Information
11.8.2 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product Offered
11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 A&G Pharmaceutical Main Business Overview
11.8.5 A&G Pharmaceutical Latest Developments
11.9 Affymetrix Inc
11.9.1 Affymetrix Inc Company Information
11.9.2 Affymetrix Inc Non-Invasive Cancer Diagnostics Product Offered
11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Affymetrix Inc Main Business Overview
11.9.5 Affymetrix Inc Latest Developments
11.10 Precision Therapeutics
11.10.1 Precision Therapeutics Company Information
11.10.2 Precision Therapeutics Non-Invasive Cancer Diagnostics Product Offered
11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Precision Therapeutics Main Business Overview
11.10.5 Precision Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Invasive Cancer Diagnostics Market Size 2019-2030
2.1.2 Non-Invasive Cancer Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Non-Invasive Cancer Diagnostics Segment by Type
2.2.1 CTCs
2.2.2 CTNAS
2.2.3 Exosomes
2.3 Non-Invasive Cancer Diagnostics Market Size by Type
2.3.1 Non-Invasive Cancer Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Non-Invasive Cancer Diagnostics Segment by Application
2.4.1 Blood
2.4.2 Urine
2.4.3 Saliva
2.5 Non-Invasive Cancer Diagnostics Market Size by Application
2.5.1 Non-Invasive Cancer Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
3 NON-INVASIVE CANCER DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Non-Invasive Cancer Diagnostics Market Size Market Share by Players
3.1.1 Global Non-Invasive Cancer Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Non-Invasive Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE CANCER DIAGNOSTICS BY REGIONS
4.1 Non-Invasive Cancer Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Non-Invasive Cancer Diagnostics Market Size Growth (2019-2024)
4.3 APAC Non-Invasive Cancer Diagnostics Market Size Growth (2019-2024)
4.4 Europe Non-Invasive Cancer Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024)
5.2 Americas Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)
5.3 Americas Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Cancer Diagnostics Market Size by Region (2019-2024)
6.2 APAC Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)
6.3 APAC Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Invasive Cancer Diagnostics by Country (2019-2024)
7.2 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)
7.3 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Invasive Cancer Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE CANCER DIAGNOSTICS MARKET FORECAST
10.1 Global Non-Invasive Cancer Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Non-Invasive Cancer Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Non-Invasive Cancer Diagnostics Forecast
10.1.3 APAC Non-Invasive Cancer Diagnostics Forecast
10.1.4 Europe Non-Invasive Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Non-Invasive Cancer Diagnostics Forecast
10.2 Americas Non-Invasive Cancer Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Non-Invasive Cancer Diagnostics Market Forecast
10.2.2 Canada Non-Invasive Cancer Diagnostics Market Forecast
10.2.3 Mexico Non-Invasive Cancer Diagnostics Market Forecast
10.2.4 Brazil Non-Invasive Cancer Diagnostics Market Forecast
10.3 APAC Non-Invasive Cancer Diagnostics Forecast by Region (2025-2030)
10.3.1 China Non-Invasive Cancer Diagnostics Market Forecast
10.3.2 Japan Non-Invasive Cancer Diagnostics Market Forecast
10.3.3 Korea Non-Invasive Cancer Diagnostics Market Forecast
10.3.4 Southeast Asia Non-Invasive Cancer Diagnostics Market Forecast
10.3.5 India Non-Invasive Cancer Diagnostics Market Forecast
10.3.6 Australia Non-Invasive Cancer Diagnostics Market Forecast
10.4 Europe Non-Invasive Cancer Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Non-Invasive Cancer Diagnostics Market Forecast
10.4.2 France Non-Invasive Cancer Diagnostics Market Forecast
10.4.3 UK Non-Invasive Cancer Diagnostics Market Forecast
10.4.4 Italy Non-Invasive Cancer Diagnostics Market Forecast
10.4.5 Russia Non-Invasive Cancer Diagnostics Market Forecast
10.5 Middle East & Africa Non-Invasive Cancer Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Non-Invasive Cancer Diagnostics Market Forecast
10.5.2 South Africa Non-Invasive Cancer Diagnostics Market Forecast
10.5.3 Israel Non-Invasive Cancer Diagnostics Market Forecast
10.5.4 Turkey Non-Invasive Cancer Diagnostics Market Forecast
10.5.5 GCC Countries Non-Invasive Cancer Diagnostics Market Forecast
10.6 Global Non-Invasive Cancer Diagnostics Forecast by Type (2025-2030)
10.7 Global Non-Invasive Cancer Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Gen-Probe Inc
11.1.1 Gen-Probe Inc Company Information
11.1.2 Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Offered
11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Gen-Probe Inc Main Business Overview
11.1.5 Gen-Probe Inc Latest Developments
11.2 Digene Corporation
11.2.1 Digene Corporation Company Information
11.2.2 Digene Corporation Non-Invasive Cancer Diagnostics Product Offered
11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Digene Corporation Main Business Overview
11.2.5 Digene Corporation Latest Developments
11.3 Quest Diagnostics Inc
11.3.1 Quest Diagnostics Inc Company Information
11.3.2 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Offered
11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Quest Diagnostics Inc Main Business Overview
11.3.5 Quest Diagnostics Inc Latest Developments
11.4 Cancer, Genetics Inc
11.4.1 Cancer, Genetics Inc Company Information
11.4.2 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Offered
11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Cancer, Genetics Inc Main Business Overview
11.4.5 Cancer, Genetics Inc Latest Developments
11.5 BIOVIEW Inc
11.5.1 BIOVIEW Inc Company Information
11.5.2 BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Offered
11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BIOVIEW Inc Main Business Overview
11.5.5 BIOVIEW Inc Latest Developments
11.6 AVIVA Biosciences Corporation
11.6.1 AVIVA Biosciences Corporation Company Information
11.6.2 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Offered
11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AVIVA Biosciences Corporation Main Business Overview
11.6.5 AVIVA Biosciences Corporation Latest Developments
11.7 Laboratory Corporation of America Holdings (LabCorp)
11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Information
11.7.2 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Offered
11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Laboratory Corporation of America Holdings (LabCorp) Main Business Overview
11.7.5 Laboratory Corporation of America Holdings (LabCorp) Latest Developments
11.8 A&G Pharmaceutical
11.8.1 A&G Pharmaceutical Company Information
11.8.2 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product Offered
11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 A&G Pharmaceutical Main Business Overview
11.8.5 A&G Pharmaceutical Latest Developments
11.9 Affymetrix Inc
11.9.1 Affymetrix Inc Company Information
11.9.2 Affymetrix Inc Non-Invasive Cancer Diagnostics Product Offered
11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Affymetrix Inc Main Business Overview
11.9.5 Affymetrix Inc Latest Developments
11.10 Precision Therapeutics
11.10.1 Precision Therapeutics Company Information
11.10.2 Precision Therapeutics Non-Invasive Cancer Diagnostics Product Offered
11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Precision Therapeutics Main Business Overview
11.10.5 Precision Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Non-Invasive Cancer Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of CTCs
Table 3. Major Players of CTNAS
Table 4. Major Players of Exosomes
Table 5. Non-Invasive Cancer Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 8. Non-Invasive Cancer Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 11. Global Non-Invasive Cancer Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Player (2019-2024)
Table 13. Non-Invasive Cancer Diagnostics Key Players Head office and Products Offered
Table 14. Non-Invasive Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Non-Invasive Cancer Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Regions (2019-2024)
Table 19. Global Non-Invasive Cancer Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Non-Invasive Cancer Diagnostics Market Size Market Share by Country (2019-2024)
Table 23. Americas Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 25. Americas Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 27. APAC Non-Invasive Cancer Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Table 29. APAC Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. APAC Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. Europe Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Country (2019-2024)
Table 35. Europe Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. Europe Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Non-Invasive Cancer Diagnostics
Table 46. Key Market Challenges & Risks of Non-Invasive Cancer Diagnostics
Table 47. Key Industry Trends of Non-Invasive Cancer Diagnostics
Table 48. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Non-Invasive Cancer Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Gen-Probe Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 53. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Offered
Table 54. Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Gen-Probe Inc Main Business
Table 56. Gen-Probe Inc Latest Developments
Table 57. Digene Corporation Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 58. Digene Corporation Non-Invasive Cancer Diagnostics Product Offered
Table 59. Digene Corporation Main Business
Table 60. Digene Corporation Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Digene Corporation Latest Developments
Table 62. Quest Diagnostics Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 63. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Offered
Table 64. Quest Diagnostics Inc Main Business
Table 65. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Quest Diagnostics Inc Latest Developments
Table 67. Cancer, Genetics Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 68. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Offered
Table 69. Cancer, Genetics Inc Main Business
Table 70. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Cancer, Genetics Inc Latest Developments
Table 72. BIOVIEW Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 73. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Offered
Table 74. BIOVIEW Inc Main Business
Table 75. BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. BIOVIEW Inc Latest Developments
Table 77. AVIVA Biosciences Corporation Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 78. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Offered
Table 79. AVIVA Biosciences Corporation Main Business
Table 80. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. AVIVA Biosciences Corporation Latest Developments
Table 82. Laboratory Corporation of America Holdings (LabCorp) Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 83. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Offered
Table 84. Laboratory Corporation of America Holdings (LabCorp) Main Business
Table 85. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Laboratory Corporation of America Holdings (LabCorp) Latest Developments
Table 87. A&G Pharmaceutical Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 88. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product Offered
Table 89. A&G Pharmaceutical Main Business
Table 90. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. A&G Pharmaceutical Latest Developments
Table 92. Affymetrix Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 93. Affymetrix Inc Non-Invasive Cancer Diagnostics Product Offered
Table 94. Affymetrix Inc Main Business
Table 95. Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Affymetrix Inc Latest Developments
Table 97. Precision Therapeutics Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 98. Precision Therapeutics Non-Invasive Cancer Diagnostics Product Offered
Table 99. Precision Therapeutics Main Business
Table 100. Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Precision Therapeutics Latest Developments
.
Table 1. Non-Invasive Cancer Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of CTCs
Table 3. Major Players of CTNAS
Table 4. Major Players of Exosomes
Table 5. Non-Invasive Cancer Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 8. Non-Invasive Cancer Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 11. Global Non-Invasive Cancer Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Player (2019-2024)
Table 13. Non-Invasive Cancer Diagnostics Key Players Head office and Products Offered
Table 14. Non-Invasive Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Non-Invasive Cancer Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Regions (2019-2024)
Table 19. Global Non-Invasive Cancer Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Non-Invasive Cancer Diagnostics Market Size Market Share by Country (2019-2024)
Table 23. Americas Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 25. Americas Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 27. APAC Non-Invasive Cancer Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Table 29. APAC Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. APAC Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. Europe Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Country (2019-2024)
Table 35. Europe Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. Europe Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Non-Invasive Cancer Diagnostics
Table 46. Key Market Challenges & Risks of Non-Invasive Cancer Diagnostics
Table 47. Key Industry Trends of Non-Invasive Cancer Diagnostics
Table 48. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Non-Invasive Cancer Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Gen-Probe Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 53. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Offered
Table 54. Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Gen-Probe Inc Main Business
Table 56. Gen-Probe Inc Latest Developments
Table 57. Digene Corporation Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 58. Digene Corporation Non-Invasive Cancer Diagnostics Product Offered
Table 59. Digene Corporation Main Business
Table 60. Digene Corporation Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Digene Corporation Latest Developments
Table 62. Quest Diagnostics Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 63. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Offered
Table 64. Quest Diagnostics Inc Main Business
Table 65. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Quest Diagnostics Inc Latest Developments
Table 67. Cancer, Genetics Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 68. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Offered
Table 69. Cancer, Genetics Inc Main Business
Table 70. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Cancer, Genetics Inc Latest Developments
Table 72. BIOVIEW Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 73. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Offered
Table 74. BIOVIEW Inc Main Business
Table 75. BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. BIOVIEW Inc Latest Developments
Table 77. AVIVA Biosciences Corporation Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 78. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Offered
Table 79. AVIVA Biosciences Corporation Main Business
Table 80. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. AVIVA Biosciences Corporation Latest Developments
Table 82. Laboratory Corporation of America Holdings (LabCorp) Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 83. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Offered
Table 84. Laboratory Corporation of America Holdings (LabCorp) Main Business
Table 85. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Laboratory Corporation of America Holdings (LabCorp) Latest Developments
Table 87. A&G Pharmaceutical Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 88. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product Offered
Table 89. A&G Pharmaceutical Main Business
Table 90. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. A&G Pharmaceutical Latest Developments
Table 92. Affymetrix Inc Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 93. Affymetrix Inc Non-Invasive Cancer Diagnostics Product Offered
Table 94. Affymetrix Inc Main Business
Table 95. Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Affymetrix Inc Latest Developments
Table 97. Precision Therapeutics Details, Company Type, Non-Invasive Cancer Diagnostics Area Served and Its Competitors
Table 98. Precision Therapeutics Non-Invasive Cancer Diagnostics Product Offered
Table 99. Precision Therapeutics Main Business
Table 100. Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Precision Therapeutics Latest Developments
LIST OF FIGURES
.
Figure 1. Non-Invasive Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Non-Invasive Cancer Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Non-Invasive Cancer Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Non-Invasive Cancer Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Type in 2023
Figure 10. Non-Invasive Cancer Diagnostics in Blood
Figure 11. Global Non-Invasive Cancer Diagnostics Market: Blood (2019-2024) & ($ Millions)
Figure 12. Non-Invasive Cancer Diagnostics in Urine
Figure 13. Global Non-Invasive Cancer Diagnostics Market: Urine (2019-2024) & ($ Millions)
Figure 14. Non-Invasive Cancer Diagnostics in Saliva
Figure 15. Global Non-Invasive Cancer Diagnostics Market: Saliva (2019-2024) & ($ Millions)
Figure 16. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Non-Invasive Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Non-Invasive Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Non-Invasive Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Non-Invasive Cancer Diagnostics Value Market Share by Country in 2023
Figure 24. United States Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Type in 2023
Figure 30. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Application in 2023
Figure 31. China Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. United States Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. China Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. India Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. France Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. UK Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Global Non-Invasive Cancer Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Non-Invasive Cancer Diagnostics Market Size Market Share Forecast by Application (2025-2030)
.
Figure 1. Non-Invasive Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Non-Invasive Cancer Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Non-Invasive Cancer Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Non-Invasive Cancer Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Type in 2023
Figure 10. Non-Invasive Cancer Diagnostics in Blood
Figure 11. Global Non-Invasive Cancer Diagnostics Market: Blood (2019-2024) & ($ Millions)
Figure 12. Non-Invasive Cancer Diagnostics in Urine
Figure 13. Global Non-Invasive Cancer Diagnostics Market: Urine (2019-2024) & ($ Millions)
Figure 14. Non-Invasive Cancer Diagnostics in Saliva
Figure 15. Global Non-Invasive Cancer Diagnostics Market: Saliva (2019-2024) & ($ Millions)
Figure 16. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Non-Invasive Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Non-Invasive Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Non-Invasive Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Non-Invasive Cancer Diagnostics Value Market Share by Country in 2023
Figure 24. United States Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Type in 2023
Figure 30. APAC Non-Invasive Cancer Diagnostics Market Size Market Share by Application in 2023
Figure 31. China Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Non-Invasive Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. United States Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. China Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. India Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. France Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. UK Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Non-Invasive Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Global Non-Invasive Cancer Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Non-Invasive Cancer Diagnostics Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Medical Gas Pressure Regulators Market Growth 2026-2032
US$ 3,660.00
July 2026
139 pages
Global Valacyclovir Market Growth 2023-2029
US$ 3,660.00
March 2023
121 pages
Global Induced Pluripotent Stem Cells (iPSCs) Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
83 pages
Global Venlafaxine Hydrochloride Market Growth 2024-2030
US$ 3,660.00
February 2024
87 pages
Global Cabergoline Market Growth 2025-2031
US$ 3,660.00
January 2025
95 pages
